Phenotypes of Parkinson's Disease 2022
Welcome to the Phenotypes of Parkinson’s disease 2022 course. The goal of the course is to describe basic clinical phenotypes for Parkinson’s related genes.
Designed to view on screen and/or listen on the go, these short lessons provide key and relevant information to help you initiate conversations regarding genetic forms of PD with patients and family members.
To receive your Continuing Education of 0.25 credits, you must complete all 4 lessons and a quiz.
First, take the pre-course quiz with five questions. There are no expectations for you to answer the questions correctly!
Next, start with Welcome to Phenotypes of Parkinson’s disease. After watching each lesson, references shared in the video and other resources will be available for you to view and download.
At the end of the course, you will be required to take a post-course quiz with 4 questions and attain a passing grade of 80% or higher. You will also need to complete the online evaluation to receive your certificate. If you are not taking this course for CE credit, you will receive a certificate of completion after completing the quizzes and evaluation.
As knowledge application is measured by adapting change in practice, you will also receive a 60-day follow-up evaluation to assess any change in your practice and interprofessional care strategies.
At the end of this activity, learners will be able to:
- Recall phenotypic variation
- Identify clinical phenotypes of PD associated genes
- Explain implications for patients and family
Thomas F Tropea, DO, MTR: Professor CE University of Pennsylvania Perelman School of Medicine
Biography: Dr. Thomas F Tropea graduated from University of New England College of Osteopathic Medicine. He completed residency in Neurology at NY Presbyterian Hospital-Weill Cornell Medical College and Memorial Sloan-Kettering, fellowship and research post-doc in movement disorders at the University of Pennsylvania. He is an Assistant Professor in Neurology at the University of Pennsylvania. His research focuses on understanding common risks among different neurodegenerative diseases, characterizing genetic subgroups of Parkinson’s disease, and optimizing disclosure of genetic results.
Disclosure: Thomas F. Tropea, DO, MTR would like to disclosure he is a consultant for Sanofi-Genzyme.
- 0.25 AAPA Category I CME
- 0.25 AMA PRA Category 1 Credit™
- 0.25 ANCC
- 0.25 Participation